(Q40852691)

24 September 2017

Apoptotic responsiveness of the Ewing's sarcoma family of tumours to tumour necrosis factor-related apoptosis-inducing ligand (TRAIL). (English)

1 reference

24 September 2017

0 references

0 references

0 references

2

1 reference

24 September 2017

Klaus-Michael Debatin

14

1 reference

24 September 2017

B Dockhorn-Dworniczak

11

object named as

B Dockhorn-Dworniczak

1 reference

24 September 2017

F Van Valen

1

1 reference

24 September 2017

B Truckenbrod

3

1 reference

24 September 2017

V Eckervogt

4

1 reference

24 September 2017

J Sonnemann

5

1 reference

24 September 2017

A Hillmann

6

1 reference

24 September 2017

R Rödl

7

1 reference

24 September 2017

C Hoffmann

8

1 reference

24 September 2017

W Winkelmann

9

1 reference

24 September 2017

L Schäfer

10

1 reference

24 September 2017

T Wessel

12

1 reference

24 September 2017

J Boos

13

1 reference

24 September 2017

H Jürgens

15

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 October 2000

1 reference

International Journal of Cancer

24 September 2017

1 reference

24 September 2017

88

1 reference

24 September 2017

252-259

1 reference

24 September 2017

2

1 reference

describes a project that uses

24 September 2017

ICB-104

0 references

MM-83

0 references

cites work

Safety and antitumor activity of recombinant soluble Apo2 ligand

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001015%2988%3A2%3C252%3A%3AAID-IJC17%3E3.0.CO%3B2-U

Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001015%2988%3A2%3C252%3A%3AAID-IJC17%3E3.0.CO%3B2-U

The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001015%2988%3A2%3C252%3A%3AAID-IJC17%3E3.0.CO%3B2-U

Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001015%2988%3A2%3C252%3A%3AAID-IJC17%3E3.0.CO%3B2-U

p27Kip1 induces drug resistance by preventing apoptosis upstream of cytochrome c release and procaspase-3 activation in leukemic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001015%2988%3A2%3C252%3A%3AAID-IJC17%3E3.0.CO%3B2-U

Mitochondrial control of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001015%2988%3A2%3C252%3A%3AAID-IJC17%3E3.0.CO%3B2-U

Apoptosis induction by caspase-8 is amplified through the mitochondrial release of cytochrome c.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001015%2988%3A2%3C252%3A%3AAID-IJC17%3E3.0.CO%3B2-U

Proteasome inhibitors: valuable new tools for cell biologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001015%2988%3A2%3C252%3A%3AAID-IJC17%3E3.0.CO%3B2-U

Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001015%2988%3A2%3C252%3A%3AAID-IJC17%3E3.0.CO%3B2-U

Caspases disrupt mitochondrial membrane barrier function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001015%2988%3A2%3C252%3A%3AAID-IJC17%3E3.0.CO%3B2-U

The interleukin-1 beta converting enzyme family of cysteine proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001015%2988%3A2%3C252%3A%3AAID-IJC17%3E3.0.CO%3B2-U

Superinduction of NF-kappa B by actinomycin D and cycloheximide in epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001015%2988%3A2%3C252%3A%3AAID-IJC17%3E3.0.CO%3B2-U

An antagonist decoy receptor and a death domain-containing receptor for TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001015%2988%3A2%3C252%3A%3AAID-IJC17%3E3.0.CO%3B2-U

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001015%2988%3A2%3C252%3A%3AAID-IJC17%3E3.0.CO%3B2-U

Two CD95 (APO-1/Fas) signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001015%2988%3A2%3C252%3A%3AAID-IJC17%3E3.0.CO%3B2-U

Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001015%2988%3A2%3C252%3A%3AAID-IJC17%3E3.0.CO%3B2-U

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001015%2988%3A2%3C252%3A%3AAID-IJC17%3E3.0.CO%3B2-U

Tumor necrosis factor receptor and Fas signaling mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001015%2988%3A2%3C252%3A%3AAID-IJC17%3E3.0.CO%3B2-U

Identification and characterization of a new member of the TNF family that induces apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001015%2988%3A2%3C252%3A%3AAID-IJC17%3E3.0.CO%3B2-U

Diagnostic value of the molecular genetic detection of the t(11;22) translocation in Ewing's tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001015%2988%3A2%3C252%3A%3AAID-IJC17%3E3.0.CO%3B2-U

10.1002/1097-0215(20001015)88:2<252::AID-IJC17>3.0.CO;2-U

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference